A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008251/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the safety, pharmacokinetics and efficacy of a single
dose of ALD403 in the prevention of migraine headache in frequent episodic migraineurs for 24
weeks.
提供机构：
Vivli
创建时间：
2022-07-15
